Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Crovalimab in the paroxysmal nocturnal hemoglobinuria treatment landscape

Class:IdLiteratureReference:9956959
_displayNameCrovalimab in the paroxysmal nocturnal hemoglobinuria treatment landscape
_timestamp2025-06-17 02:52:42
author[Person:9956962] Röth, Alexander
[Person:9956945] Kulasekararaj, Austin G
[Person:9956947] Scheinberg, Phillip
[Person:9956948] Nishimura, Jun-Ichi
created[InstanceEdit:9956951] Shamovsky, Veronica, 2025-06-17
journalImmunotherapy
pages1185-1196
pubMedIdentifier39620653
titleCrovalimab in the paroxysmal nocturnal hemoglobinuria treatment landscape
volume16
year2024
(literatureReference)[Reaction:9691621] C5 binds C5 inhibitors [Homo sapiens]
[Summation:9691612] Activation of the complement system significantly contribute...
[Change default viewing format]
No pathways have been reviewed or authored by Crovalimab in the paroxysmal nocturnal hemoglobinuria treatment landscape (9956959)